Rhode Island Chronicle

Grand View Research, Inc. – Market Research And Consulting

The global intravenous (IV) iron drugs market size is expected to reach USD 2.90 billion by 2026,expanding at a CAGR of 7.2% during the forecast period, according to a new report by Grand View Research. Growing prevalence of chronic diseases, noncompliance of oral drug treatment and recent approvals of novel products are the key factors driving the IV iron drugs market. However, some of the factors that are restraining the market include the adverse side effects, stringent regulations, availability of nutraceutical alternatives, and complex approval process.

Iron is one of the crucial components in the hemoglobin and plays an important role in the transportation of oxygen throughout the body. It also takes part in several biological processes such as energy metabolism, formation of collagen, the synthesis of heme, formation of myoglobin, immune system functions, and neurotransmitter production. Around 30% of anemia in women and children in developing nations is caused by deficiency of iron according to a survey conducted by the Vitamin and Mineral Nutrition Information System in 2017. Growing cases of chronic kidney diseases, iron deficiency anemia in gastroenterology, gynecology and oncology and growing cohort with high rate of unresponsive oral therapy is expected to drive the demand for these drugs. Furthermore, increasing healthcare expenditure and high accuracy, sensitivity and easy access of intravenous iron drugs fuels the market growth.

Among the products, the ferric carboxymaltose segment dominated the global intravenous iron drugs market in 2018 and is expected to grow significantly due to its increasing application in drug discovery processes, superior performance, and reduced cost. Ferric carboxymaltose is marketed as Injectafer in North America and under the name of Ferinject outside North America. Asia Pacific is projected to demonstrate the highest CAGR during the forecast period, while North America held the largest market share in 2018.

“Read Report Summary, Toc, Market Segmentation, Research Methodology, Request a Free Sample“ Intravenous Iron Drugs Market Click the link below:
www.grandviewresearch.com/industry-analysis/intravenous-iron-drugs-market

Request a Free Sample Report Intravenous Iron Drugs Market” Click the link below:
www.grandviewresearch.com/industry-analysis/intravenous-iron-drugs-market/request/rs1

Further Key Findings From the Study Suggest:

•  Among the applications, chronic kidney disease segment held the largest IV iron drugs market share in 2018, due to increasing prevalence and geriatric population

• Ferric carboxymaltose is expected to maintain its dominance through the forecast period due to the increasing application in drug discovery, superior performance and reduced cost

• Asia Pacific is projected to exhibit the fastest growth during the forecast period, which can be attributed to the increasing prevalence of chronic diseases in the region, improving healthcare infrastructure, and rising per capita healthcare expenditure

• Key players operating in the intravenous iron drugs market include Allergan, Inc.,AMAG Pharmaceuticals. Inc.,Daiichi Sankyo Company, Ltd., Sanofi, Fresenius Medical Care AG & Co., Vifor Pharma Management Ltd., Pharmacosmos A/S, Shield Therapeutics Plc, and American Regent. Inc.

Have Any Query? Ask Our Experts (Inquiry Before Buying) Intravenous Iron Drugs Market:
www.grandviewresearch.com/inquiry/1935/ibb

Curious to know more? (Request a Free Sample) Click the link below: 
www.grandviewresearch.com/industry-analysis/intravenous-iron-drugs-market/request/rs1

Grand View Research has segmented the intravenous iron drugs market report on the basis of product, application, and region:

Intravenous Iron Drugs Product Outlook (Revenue, USD Million, 2015 – 2026)

• Iron Dextran

• Iron Sucrose

• Ferric Carboxymaltose

• Others

Intravenous Iron Drugs Application Outlook (Revenue, USD Million, 2015 – 2026)

• Chronic Kidney Disease

• Inflammatory Bowel Disease

• Cancer

• Other Diseases

Intravenous Iron Drugs Regional Outlook (Revenue, USD Million, 2015 – 2026)

• North America 

  • U.S.

  • Canada

• Europe 

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Russia

• Asia Pacific 

  • Japan

  • China

  • India

  • South Korea

  • Singapore

  • Australia

• Latin America 

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

• South Africa

• Saudi Arabia

• UAE

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

If you need specific information, which is not currently within the article, we will provide it to you as a part of customization

Intravenous Iron Drugs Market Request for Customization:
www.grandviewresearch.com/request-for-customization/1935/rfc

Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 26 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 426 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 600 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States
Website: https://www.grandviewresearch.com/industry-analysis/intravenous-iron-drugs-market